Asymptotic AI is a cross-industry tech startup company that provides ready-to-use AI solutions to our customers. We offer customized data platforms for our customers to enable their end-to-end big data analytics.
The functionalities of the data platform include: efficient pipeline for raw data transformation and normalization; data visualization; search engine optimized for big data; blockchain technology; data fusion and HD map construction; active learning and automatic labelling; deep learning based image processing, object detection, classification and regression algorithms. Our products are offered as a service running on the Asymptotic AI platform or a software deliverable tailored to a specific target hardware.
We work closely with our customers and partners towards scalable, reliable and interpretable AI applications.
Is your data in a standard format? We have state-of-the-art algorithms off-the-shelf solutions for data management, computer vision, machine learning, ready to be deployed on your data today.
Do you have a complex project with specific requirements on data management, security or algorithms? We can customize our tools to your specific needs and shorten your time to market.
We can also help you to empower your team by elevating their knowledge in AI. We can offer education from a introductory to a deep technical level or how to efficiently incorporating AI into your business.
Boost your business today
with our AI services
Partners and Customers
IT Infrastructure - for a brighter future
CGit was started by engineers and is still run by engineers. We provide the market with cutting edge expertise and market leading advanced IT-solutions. With commitment, availability and flexibility we help companies get the most out their IT platform and generate maximum business benefits from their investments. We view IT as essential to help create a better future. We at CGit assist with expertise, whether it is about offering better education for our children, a safer work environment for shop staff, or a more efficient daily life for everyone at your company. This may be in individual projects, designing new solutions, or installing and operating IT infrastructure for organisations.
IGLAD - global and harmonized in-depth accident data
IGLAD was initiated in 2010 by European car manufacturers and is an initiative for harmonisation of global in-depth traffic accident data to improve road and vehicle safety. The goal of the group is to define a common standardized accident data set as an effective foundation for developing and measuring road safety policy endorsements and interventions. The database of international in-depth traffic accidents created in the group is widely used to foster the development, assurance and verification of new safety technologies making them ready for real world applications.
We research to save lives, prevent injuries and enable safe mobility. Together.
"Zero injuries in road traffic" – that's our drive and overall goal. We are the open innovation arena where researchers and expertise work together to create safe mobility. Our traffic safety approach covers people, vehicles and the infrastructure – and together we contribute to safer road transports and smarter, more sustainable cities. Join us!
REVERE - Resource for Vehicle Research at Chalmers
Revere is a research facility focusing on automotive-related research. Main focus areas are self-driving vehicles, active safety and vehicle dynamics. Lab resources include test vehicles (light & heavy vehicles), environment sensors among other vehicle-related equipment. The lab is 400 m² facility located in Lindholmen, 10 min from Lindholmen Science Park.
Assessing biodiversity using DNA
We specialize in environmental monitoring and assessment. We use DNA based technologies to track individual species and assess biodiversity of macro- and microorganisms.
Medfield Diagnostics AB develops medical device based on microwave technology
Medfield Diagnostics AB (publ) aims to improve diagnosis of brain injuries. Early diagnosis will enable faster treatment, minimise unnecessary suffering for the patient, improve outcomes and lead to cost savings for healthcare and society.